Skip to search formSkip to main contentSkip to account menu

Meretoja syndrome

Known as: Meretoja's syndrome, Amyloidosis, Finnish Type, Amyloidosis 5 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Vutrisiran (ALN‐TTRsc02) is a liver‐directed, investigational, small interfering ribonucleic acid drug for the treatment of… 
Review
2017
Review
2017
Hereditary transthyretin (ATTR) amyloidosis is a debilitating highly penetrant autosomal dominant disease leading to motor… 
Review
2016
Review
2016
Transthyretin (TTR) transports the retinol-binding protein–vitamin A complex and is a minor transporter of thyroxine in blood… 
Review
2015
Review
2015
Abstract Background: Hereditary transthyretin amyloidosis (ATTR amyloidosis) is a rare, clinically heterogeneous disease due to… 
Highly Cited
2014
Highly Cited
2014
The development of an effective therapy for Alzheimer’s disease (AD) is a major challenge to biomedical sciences. Because much of… 
Highly Cited
2014
Highly Cited
2014
Amyloid β-peptide (Aβ) accumulation is a key characteristic of Alzheimer's disease (AD); therefore, mouse models of AD exhibiting… 
Review
2012
Review
2012
Protein misassembly into aggregate structures, including cross-β-sheet amyloid fibrils, is linked to diseases characterized by… 
Highly Cited
2008
Highly Cited
2008
The amyloid-β42 (Aβ42) peptide has been suggested to play a causative role in Alzheimer disease (AD). Neprilysin (NEP) is one of…